IVDD to IVDR Transition Support

Making the leap from IVDD to IVDR can feel overwhelming—but it doesn’t have to be. With the right guidance, this regulatory shift is more than a hurdle; it’s an opportunity to elevate your in vitro diagnostic devices to the highest standards of safety, performance, and market readiness.

At QbD Group, we combine deep regulatory expertise with hands-on industry experience to help you meet IVDR requirements efficiently and strategically. Whether you're just starting your transition or fine-tuning your technical documentation, our experts are here to support every step — so you stay compliant, confident, and competitive.

Get in touch

Why early action is key

With average certification timelines ranging from 13–18 months and transition deadlines fast approaching, IVD manufacturers can’t afford to wait. Planning early not only ensures compliance—it gives you a competitive edge.

Challenges manufacturers face

Understanding the urgency is only the first step.

As deadlines approach, many IVD manufacturers find themselves unprepared — not because they lack intention, but because they underestimate the complexity of the transition.

Without a clear plan, adequate resources, and compliant documentation, even well-established organizations risk falling behind.

Certification delays now exceed 1 year in some cases

Written NB agreements required 2 years in advance

No significant changes allowed during transition

QMS must be IVDR-compliant by May 2025

Quality Assurance

ISO 13485 certificate does not guarantee IVDR compliance
Create/update processes, procedures, templates

Regulatory Affairs

Define Regulatory Strategy:
- Define products in
  scope of transition
- Define strategy
  for submission to NB
Setting up collaboration with Notified Bodies (selection, contracting, planning)

Technical Documentation

New IVDR requirements need to be addressed
Additional Clinical Evidence Activities
Compile Summary of Technical Documentation (STED) ready
for NB review

Our IVDR transition approach

We support you from initial assessment to final submission. Whether you’re reworking your QMS, compiling your STED file, or need Notified Body coordination, we’re here to guide the process from A to Z.

Quality Assurance

Gap assessment & mock audits
IVDR-compliant SOPs and QMS updates
Custom documentation & procedures

Learn more

Regulatory Affairs

Regulatory roadmap & product scoping
NB selection, planning & submission strategy
Technical Documentation & submission support

Learn more

Clinical & Medical Writing

Performance evaluation plans & studies
Scientific validity & analytical performance
Writing of STED, PER, PEP, LRP, and more

Learn more

Why partner with QbD for your IVDR transition?

End-to-end IVD expertise
QA, RA, Clinical, and Medical Writing—fully covered by senior specialists.
Tailor-made transition plans
Roadmaps aligned with your portfolio, internal capacity, and timelines.
Proven success across 100+ submissions
We've written over 100 IVDR Technical Documentations since 2018.
Recognized by Notified Bodies
BSI and GMED recommend expert-reviewed documentation—QbD is that expert.
Accelerated time-to-submission
Reduce your prep time by 25–50% with our focused, structured approach.
Hands-on, pragmatic support
From kick-off to submission, we guide and coordinate every step of the way.

Your step-by-step path to IVDR compliance

Navigating the IVDD to IVDR transition doesn’t have to be overwhelming. Our structured 8-step approach guides you from initial scoping to final submission, ensuring every requirement is met with clarity, quality, and confidence.

Project scoping & kick-off

Define the project scope and assemble a multidisciplinary team with a dedicated project manager.

1

Regulatory Strategy

Qualify and classify devices under IVDR and ensure alignment with PMS and PMPF requirements.

2

Gap Assessment

Review technical documentation and assess your QMS and clinical evidence for IVDR readiness.

3

Transition Strategy

Build a roadmap to close gaps in QMS, technical documentation, and clinical requirements.

4

Change Management

Train all relevant teams to align internal processes with IVDR obligations.

5

Remediation Strategy

Address documentation gaps, update procedures, and implement an IVDR-compliant QMS.

6

Mock Audit / Assessment

Conduct internal audits and review documentation to confirm IVDR compliance.

7

Submission

Submit your QMS and technical documentation for formal IVDR assessment.

8

IVDR client cases: successful transitions in practice

From small-scale innovators to large manufacturers, our IVDR clients trust QbD to guide them through complex transitions with clarity and confidence. Explore how we’ve helped companies streamline documentation, reduce timelines, and achieve compliance—on time and with quality recognized by Notified Bodies.

Large-scale Transition – 48 Class C Devices

Supported a full IVDR transition for 48 Class C products within the same generic device group.
Assigned 8 senior consultants and ~1.5 FTE for strategy, documentation, and submission.
Used a phased submission strategy—first certification achieved in just 12 months.
Complete IVDR certification of all products finalized within 22 months.

Need support with your case? Get in touch!

Small Oncology Company – NGS & Software

Assisted a small-scale company in transitioning NGS-based IVDs combined with software.
Completed QMS and documentation gap assessment in Q4 2023.
Provided full remediation, including clinical evidence, usability, and STED creation.
Submission support planned from March 2025, with a 5-member expert team.

Need support with your case? Get in touch!

Related content

Case study

A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader

QbD Group streamlines linguistic reviews for a leading pharma client, ensuring compliance and accuracy across 25 EU/EEA languages while meeting stringent regulatory deadlines.

Whitepaper

Medical Device Regulation (MDR) Checklist

Implement the Medical Device Regulation (MDR) with ease. Download our checklist of mandatory documents for MDR compliance.

Whitepaper

Regulatory Affairs for Pharma and Biotech

In this flyer, you will learn more about the regulatory services QbD Group provides for the pharmaceutical and biotechnology industries.

Whitepaper

Clinical Evaluation for Medical Devices under MDR

This whitepaper will guide you through crucial regulatory documents pertaining to the clinical evaluation process of your medical device. Download now!

Whitepaper

IVDR extension: what does this mean for you?

In this whitepaper, you will learn the impact of the IVDR transition extension and receive tips and strategies to navigate these regulatory changes.

Webinar

Drug-Device Combination Products and Article 117

Explore the regulatory complexities of Drug-Device Combination Products. Learn about Article 117 requirements, Notified Body Opinions, and more.

Whitepaper

Mobile health on the rise: exploring the regulatory landscape for reimbursement

This whitepaper will help you navigate the maze of the DTx regulatory environment, highlighting several important countries and regulations.

Whitepaper

Clinical investigations under MDR: key insights and practical experiences

This whitepaper covers clinical investigation authorization under MDR, the EU Legal Representative's role, and the MDR's impact on study conduct and post-market surveillance.

Case study

CE Mark Renewal for bioXtra Products: A Success Story

Discover how Lifestream Pharma successfully renewed the CE mark for their BioXtra Dry Mouth products under the EU MDR. Learn about the challenges faced, the approach taken for compliance, and the results achieved.

Webinar

Technical Documentation Essentials for Medical Device Software

Gain practical insights on crafting MDR-compliant technical documentation for Medical Device Software.

Webinar

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Watch our webinar on demand and learn about regulatory obstacles, MDR, AI Act, and best practices for medical device software development and market entry.

Webinar

Mastering Clinical Performance Studies under IVDR

In the evolving regulatory landscape of IVDs, demonstrating clinical performance is more crucial and challenging than ever. Discover more in this webinar on demand.

Whitepaper

Clinical evidence for In Vitro Diagnostics under IVDR

In this whitepaper, we will guide you through the documents required for the demonstration of clinical evidence under the IVDR. Download now.

Webinar

Post-Market Surveillance Requirements for Medical Devices and IVDs

Learn about post-market surveillance requirements under MDR and IVDR regulations. Gain insights from industry experts in this on-demand webinar.

Whitepaper

The key role of Regulatory Affairs in the pharmaceutical industry: from drug development to commercialization

Discover the key role of Regulatory Affairs in pharma and how Regulatory Affairs teams support product lifecycle management in this whitepaper. Download now.

Webinar

3D Printing in the Healthcare World

Explore the challenges and opportunities of 3D printing in healthcare, featuring expert insights on regulations, pitfalls, and efficiency.

Webinar

IVDR Extension Explained: Tips & Strategies

Gain valuable insights on the IVDR extension and its impact on IVD manufacturers with our webinar on demand.

Whitepaper

Innovations in ATMP: state of the industry in 2024

This whitepaper explores the innovations in ATMP and solutions in detail, with a focus on the current landscape as of April 2024. Download now.

Case study

The journey toward IVDR compliance for the LVOne device

QbD Group helped Upfront Diagnostics gain entry into the MD/IVD industry by supporting them on their path to ISO 13485 certification.

Case study

Ensuring a smooth MDR transition for Oystershell's medical devices

The landscape of medical device regulations is constantly evolving, making it a challenge for companies to keep up. Our collaboration with Oystershell, which began in July 2023, highlights our expertise in transforming complex challenges into success stories, all with a touch of QbD Clinical magic.

Case study

Successful clinical evaluation supports rapid CE marking of Minze Health's Uroflowmeter

QbD Clinical assisted Minze Health, a urology-focused medical devices company, in obtaining CE marking under MDR through clinical evaluation.

Webinar

The Medical Device CE Certification Pathway Explained: From Classification to Conformity Assessment by the Notified Body

Learn about the Medical Device CE Certification Pathway, from classification to conformity assessment by a Notified Body. Join our webinar on demand.

Case study

Helping Relu to comply with changing regulations

QbD Group supported software company Relu with their expertise to comply with changing regulations.

Case study

Quickly bringing a new COVID-19 medical device to market

Obtaining the required government certifications for a medical device is always a challenge. Especially when the COVID clock is ticking.

Discover all

IVDD to IVDR Transition Support

Why early action is key

Challenges manufacturers face

Certification delays now exceed 1 year in some cases

Written NB agreements required 2 years in advance

No significant changes allowed during transition

QMS must be IVDR-compliant by May 2025

Key areas impacted in your transition from IVDD to IVDR?

Quality Assurance

Quality Assurance

Regulatory Affairs

Regulatory Affairs

Technical Documentation

Technical Documentation

Our IVDR transition approach

Quality Assurance

Regulatory Affairs

Clinical & Medical Writing

Why partner with QbD for your IVDR transition?

Your step-by-step path to IVDR compliance

1

2

3

4

5

6

7

8

IVDR client cases: successful transitions in practice

Large-scale Transition – 48 Class C Devices

Small Oncology Company – NGS & Software

Start your IVDR transition today

Related content

A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader​

Medical Device Regulation (MDR) Checklist

Regulatory Affairs for Pharma and Biotech

Clinical Evaluation for Medical Devices under MDR

IVDR extension: what does this mean for you?

Drug-Device Combination Products and Article 117

Mobile health on the rise: exploring the regulatory landscape for reimbursement

Clinical investigations under MDR: key insights and practical experiences

CE Mark Renewal for bioXtra Products: A Success Story

Technical Documentation Essentials for Medical Device Software

Getting Started: Overcoming Initial Obstacles in Medical Device Software Development

Mastering Clinical Performance Studies under IVDR

Clinical evidence for In Vitro Diagnostics under IVDR

Post-Market Surveillance Requirements for Medical Devices and IVDs

The key role of Regulatory Affairs in the pharmaceutical industry: from drug development to commercialization

3D Printing in the Healthcare World

IVDR Extension Explained: Tips & Strategies

Innovations in ATMP: state of the industry in 2024

The journey toward IVDR compliance for the LVOne device

Ensuring a smooth MDR transition for Oystershell's medical devices

Successful clinical evaluation supports rapid CE marking of Minze Health's Uroflowmeter

The Medical Device CE Certification Pathway Explained: From Classification to Conformity Assessment by the Notified Body

Helping Relu to comply with changing regulations

Quickly bringing a new COVID-19 medical device to market

A Decade of Excellence: Linguistic Review Support for a Global Pharma Leader